Oleanolic, Ursolic, and Betulinic Acids as Food Supplements or Pharmaceutical Agents for Type 2 Diabetes: Promise or Illusion?

Journal of Agricultural and Food Chemistry

Volumn 64, Issue 15, 2016, Pages 2991-3008

  Silva, Filomena S G ^a   Oliveira, Paulo J ^b   Duarte, Maria F ^a  

^a INSTITUTO POLITÉCNICO DE BEJA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

antidiabetic; antiobesity; betulinic acid; cardiovascular disease; hepatic disease; oleanolic acid; ursolic acid

Indexed keywords

CARBOXYLIC ACIDS;

ANTI DIABETICS; ANTIOBESITY; BETULINIC ACID; CARDIO-VASCULAR DISEASE; HEPATIC DISEASE; OLEANOLIC ACIDS; URSOLIC ACID;

GLUCOSE;

ANTIDIABETIC AGENT; ANTIINFLAMMATORY AGENT; BETULIC ACID; BETULIN; OLEANOLIC ACID; TRITERPENE;

BODY WEIGHT; CHEMICAL STRUCTURE; CHEMISTRY; DIETARY SUPPLEMENT; ILLUSION; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS;

ANTI-INFLAMMATORY AGENTS; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; HYPOGLYCEMIC AGENTS; ILLUSIONS; INSULIN RESISTANCE; MOLECULAR STRUCTURE; OLEANOLIC ACID; TRITERPENES;

EID: 84966292312     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/acs.jafc.5b06021     Document Type: Review

References (175)

1. WHO, DiabetesFact Sheet 312, (2015.
2. Biggs, M. L.; Mukamal, K. J.; Luchsinger, J. A.; Ix, J. H.; Carnethon, M. R.; Newman, A. B.; de Boer, I. H.; Strotmeyer, E. S.; Mozaffarian, D.; Siscovick, D. S. Association between adiposity in midlife and older age and risk of diabetes in older adults JAMA, J. Am. Med. Assoc. 2010) 303, 2504-2512 10.1001/jama.2010.843
3. Forouhi, N. G.; Wareham, N. J. Epidemiology of diabetes Medicine 2014, 42, 698-702 10.1016/j.mpmed.2014.09.007
4. Domingues, R. M. A.; Guerra, A. R.; Duarte, M.; Freire, C. S. R.; Neto, C. P.; Silva, C. M. S.; Silvestre, A. J. D. Bioactive triterpenic acids: from agroforestry biomass residues, to promising therapeutic tools Mini-Rev. Org. Chem. 2014, 11, 382-399 10.2174/1570193X113106660001
5. Camer, D.; Yu, Y.; Szabo, A.; Huang, X. F. The molecular mechanisms underpinning the therapeutic properties of oleanolic acid, its isomer and derivatives for type 2 diabetes and associated complications Mol. Nutr. Food Res. 2014, 58, 1750-1759 10.1002/mnfr.201300861
6. Castellano, J. M.; Guinda, A.; Delgado, T.; Rada, M.; Cayuela, J. A. Biochemical basis of the antidiabetic activity of oleanolic acid and related pentacyclic triterpenes Diabetes 2013, 62, 1791-1799 10.2337/db12-1215
7. Alqahtani, A.; Hamid, K.; Kam, A.; Wong, K. H.; Abdelhak, Z.; Razmovski-Naumovski, V.; Chan, K.; Li, K. M.; Groundwater, P. W.; Li, G. Q. The pentacyclic triterpenoids in herbal medicines and their pharmacological activities in diabetes and diabetic complications Curr. Med. Chem. 2013, 20, 908-931 10.2174/092986713805219082
8. Abdel-Zaher, A. O.; Abdel-Rahman, M. M.; Hafez, M. M.; Omran, F. M. Role of nitric oxide and reduced glutathione in the protective effects of aminoguanidine, gadolinium chloride and oleanolic acid against acetaminophen-induced hepatic and renal damage Toxicology 2007, 234, 124-134 10.1016/j.tox.2007.02.014
9. Gao, J.; Tang, X.; Dou, H.; Fan, Y.; Zhao, X.; Xu, Q. Hepatoprotective activity of Terminalia catappa L. leaves and its two triterpenoids J. Pharm. Pharmacol. 2004, 56, 1449-1455 10.1211/0022357044733
10. Martin-Aragon, S.; de las Heras, B.; Sanchez-Reus, M. I.; Benedi Pharmacological modification of endogenous antioxidant enzymes by ursolic acid on tetrachloride-induced liver damage in rats and primary cultures of rat hepatocytes Exp. Toxicol. Pathol. 2001, 53, 199-206 10.1078/0940-2993-00185
11. Messner, B.; Zeller, I.; Ploner, C.; Frotschnig, S.; Ringer, T.; Steinacher-Nigisch, A.; Ritsch, A.; Laufer, G.; Huck, C.; Bernhard, D. Ursolic acid causes DNA-damage, p53-mediated, mitochondria- and caspase-dependent human endothelial cell apoptosis, and accelerates atherosclerotic plaque formation in vivo Atherosclerosis 2011, 219, 402-408 10.1016/j.atherosclerosis.2011.05.025
12. Mapanga, R. F.; Rajamani, U.; Dlamini, N.; Zungu-Edmondson, M.; Kelly-Laubscher, R.; Shafiullah, M.; Wahab, A.; Hasan, M. Y.; Fahim, M. A.; Rondeau, P.; Bourdon, E.; Essop, M. F. Oleanolic acid: a novel cardioprotective agent that blunts hyperglycemia-induced contractile dysfunction PLoS One 2012, 7, e47322 10.1371/journal.pone.0047322
13. Chan, C. Y.; Mong, M. C.; Liu, W. H.; Huang, C. Y.; Yin, M. C. Three pentacyclic triterpenes protect H9c2 cardiomyoblast cells against high-glucose-induced injury Free Radical Res. 2014, 48, 402-411 10.3109/10715762.2014.880113
14. Xia, A.; Xue, Z.; Li, Y.; Wang, W.; Xia, J.; Wei, T.; Cao, J.; Zhou, W. Cardioprotective effect of betulinic acid on myocardial ischemia reperfusion injury in rats Evidence-Based Complement. Alternat. Med. 2014, 2014, 573745 10.1155/2014/573745
15. Ma, J. Q.; Ding, J.; Xiao, Z. H.; Liu, C. M. Ursolic acid ameliorates carbon tetrachloride-induced oxidative DNA damage and inflammation in mouse kidney by inhibiting the STAT3 and NF-κB activities Int. Immunopharmacol. 2014, 21, 389-395 10.1016/j.intimp.2014.05.022
16. Khathi, A.; Serumula, M. R.; Myburg, R. B.; Van Heerden, F. R.; Musabayane, C. T. Effects of Syzygium aromaticum-derived triterpenes on postprandial blood glucose in streptozotocin-induced diabetic rats following carbohydrate challenge PLoS One 2013, 8, e81632 10.1371/journal.pone.0081632
17. Lee, J.; Lee, H. I.; Seo, K. I.; Cho, H. W.; Kim, M. J.; Park, E. M.; Lee, M. K. Effects of ursolic acid on glucose metabolism, the polyol pathway and dyslipidemia in non-obese type 2 diabetic mice Indian J. Exp. Biol. 2014, 52, 683-691
18. Wang, X.; Liu, R.; Zhang, W.; Zhang, X.; Liao, N.; Wang, Z.; Li, W.; Qin, X.; Hai, C. Oleanolic acid improves hepatic insulin resistance via antioxidant, hypolipidemic and anti-inflammatory effects Mol. Cell. Endocrinol. 2013, 376, 70-80 10.1016/j.mce.2013.06.014
19. Kim, S. J.; Quan, H. Y.; Jeong, K. J.; Kim do, Y.; Kim, G.; Jo, H. K.; Chung, S. H. J. Beneficial effect of betulinic acid on hyperglycemia via suppression of hepatic glucose production J. Agric. Food Chem. 2014, 62, 434-442 10.1021/jf4030739
20. Sundaresan, A.; Harini, R.; Pugalendi, K. V. Ursolic acid and rosiglitazone combination alleviates metabolic syndrome in high fat diet fed C57BL/6J mice Gen. Physiol. Biophys. 2012, 31, 323-333 10.4149/gpb-2012-037
21. Gao, D.; Li, Q.; Li, Y.; Liu, Z.; Fan, Y.; Liu, Z.; Zhao, H.; Li, J.; Han, Z. Antidiabetic and antioxidant effects of oleanolic acid from Ligustrum lucidum Ait in alloxan-induced diabetic rats Phytother. Res. 2009, 23, 1257-1262 10.1002/ptr.2603
22. Sundaresan, A.; Radhiga, T.; Pugalendi, K. V. Effect of ursolic acid and rosiglitazone combination on hepatic lipid accumulation in high fat diet-fed C57BL/6J mice Eur. J. Pharmacol. 2014, 741, 297-303 10.1016/j.ejphar.2014.07.032
23. Jia, Y.; Kim, S.; Kim, J.; Kim, B.; Wu, C.; Lee, J. H.; Jun, H.; Kim, N.; Lee, D.; Lee, S. Ursolic acid improves lipid and glucose metabolism in high-fat-fed C57BL/6J mice by activating peroxisome proliferator-activated receptor alpha and hepatic autophagy Mol. Nutr. Food Res. 2015, 59, 344-354 10.1002/mnfr.201400399
24. Marquez-Martin, A.; De La Puerta, R.; Fernandez-Arche, A.; Ruiz-Gutierrez, V.; Yaqoob, P. Modulation of cytokine secretion by pentacyclic triterpenes from olive pomace oil in human mononuclear cells Cytokine 2006, 36, 211-217 10.1016/j.cyto.2006.12.007
25. Ullevig, S. L.; Zhao, Q.; Zamora, D.; Asmis, R. Ursolic acid protects diabetic mice against monocyte dysfunction and accelerated atherosclerosis Atherosclerosis 2011, 219, 409-416 10.1016/j.atherosclerosis.2011.06.013
26. Ullevig, S. L.; Kim, H. S.; Nguyen, H. N.; Hambright, W. S.; Robles, A. J.; Tavakoli, S.; Asmis, S. Ursolic acid protects monocytes against metabolic stress-induced priming and dysfunction by preventing the induction of Nox4 Redox Biol. 2014, 2, 259-266 10.1016/j.redox.2014.01.003
27. Li, M.; Han, Z.; Bei, W.; Rong, X.; Guo, J.; Hu, X. Oleanolic acid attenuates insulin resistance via NF-κB to regulate the IRS1-GLUT4 pathway in HepG2 cells Evidence-Based Complement. Alternat. Med. 2015, 2015, 643102 10.1155/2015/643102
28. Li, S.; Liao, X.; Meng, F.; Wang, Y.; Sun, Z.; Guo, F.; Li, X.; Meng, M.; Li, Y.; Sun, C. Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats PLoS One 2014, 9, e86724 10.1371/journal.pone.0086724
29. Yi, J.; Xia, W.; Wu, J.; Yuan, L.; Wu, J.; Tu, D.; Fang, J.; Tan, Z. Betulinic acid prevents alcohol-induced liver damage by improving the antioxidant system in mice J. Vet. Sci. 2014, 15, 141-148 10.4142/jvs.2014.15.1.141
30. Chun, J.; Lee, C.; Hwang, S. W.; Im, J. P.; Kim, J. S. Ursolic acid inhibits nuclear factor-kappaB signaling in intestinal epithelial cells and macrophages, and attenuates experimental colitis in mice Life Sci. 2014, 110, 23-34 10.1016/j.lfs.2014.06.018
31. Yoon, J. J.; Lee, Y. J.; Kim, J. S.; Kang, D. G.; Lee, H. S. Protective role of betulinic acid on TNF-α-induced cell adhesion molecules in vascular endothelial cells Biochem. Biophys. Res. Commun. 2010, 391, 96-101 10.1016/j.bbrc.2009.11.009
32. de Melo, C. L.; Queiroz, M. G.; Fonseca, S. G.; Bizerra, A. M.; Lemos, T. L.; Melo, T. S.; Santos, T. S.; Rao, V. S. Oleanolic acid, a natural triterpenoid improves blood glucose tolerance in normal mice and ameliorates visceral obesity in mice fed a high-fat diet Chem.-Biol. Interact. 2010, 185, 59-65 10.1016/j.cbi.2010.02.028
33. Chitturi, S.; George, J. Hepatotoxicity of commonly used drugs: nonsteroidal anti-inflammatory drugs, antihypertensives, antidiabetic agents, anticonvulsants, lipid-lowering agents, psychotropic drugs Semin. Liver Dis. 2002, 22, 169-183 10.1055/s-2002-30102
34. Scheen, A. J. Pharmacokinetic and toxicological considerations for the treatment of diabetes in patients with liver disease Expert Opin. Drug Metab. Toxicol. 2014, 10, 839-857 10.1517/17425255.2014.902444
35. Yim, T. K.; Wu, W. K.; Pak, W. F.; Ko, K. M. Hepatoprotective action of an oleanolic acid-enriched extract of Ligustrum lucidum fruits is mediated through an enhancement on hepatic glutathione regeneration capacity in mice Phytother. Res. 2001, 15, 589-592 10.1002/ptr.878
36. Jeong, H. G. Inhibition of cytochrome P450 2E1 expression by oleanolic acid: hepatoprotective effects against carbon tetrachloride-induced hepatic injury Toxicol. Lett. 1999, 105, 215-222 10.1016/S0378-4274(99)00004-1
37. Bai, X.; Qiu, A.; Guan, J.; Shi, Z. Antioxidant and protective effect of an oleanolic acid-enriched extract of A. deliciosa root on carbon tetrachloride induced rat liver injury Asia Pac. J. Clin. Nutr. 2007, 16 (Suppl. 1) 169-173
38. Liu, J.; Liu, Y.; Klaassen, C. D. Protective effect of oleanolic acid against chemical-induced acute necrotic liver injury in mice Zhongguo Yao Li Xue Bao 1995, 16, 97-102
39. Liu, J.; Liu, Y.; Mao, Q.; Klaassen, C. D. The effects of 10 triterpenoid compounds on experimental liver injury in mice Toxicol. Sci. 1994, 22, 34-40 10.1093/toxsci/22.1.34
40. 4-induced oxidative stress and inflammation by the MAPK/NF-κB pathway Environ. Toxicol. Pharmacol. 2014, 37, 975-983 10.1016/j.etap.2014.03.011
41. Ma, J. Q.; Ding, J.; Zhang, L.; Liu, C. M. Protective effects of ursolic acid in an experimental model of liver fibrosis through Nrf2/ARE pathway Clin. Res. Hepatol. Gastroenterol. 2015, 39, 188-197 10.1016/j.clinre.2014.09.007
42. Zheng, Z. W.; Song, S. Z.; Wu, Y. L.; Lian, L. H.; Wan, Y.; Nan, J. X. Betulinic acid prevention of d -galactosamine/lipopolysaccharide liver toxicity is triggered by activation of Bcl-2 and antioxidant mechanisms J. Pharm. Pharmacol. 2011, 63, 572-578 10.1111/j.2042-7158.2010.01239.x
43. Kellett, G. L.; Brot-Laroche, E. Apical GLUT2: a major pathway of intestinal sugar absorption Diabetes 2005, 54, 3056-3062 10.2337/diabetes.54.10.3056
44. Van de Laar, F. A.; Lucassen, P. L.; Akkermans, R. P.; Van de Lisdonk, E. H.; Rutten, G. E.; Van Weel, C. Alpha-glucosidase inhibitors for type 2 diabetes mellitus Cochrane Database Syst. Rev. 2005, CD003639 10.1002/14651858.CD003639.pub2
45. Kumar, S.; Narwal, S.; Kumar, V.; Prakash, O. α-Glucosidase inhibitors from plants: a natural approach to treat diabetes Pharmacogn. Rev. 2011, 5, 19-29 10.4103/0973-7847.79096
46. Ali, H.; Houghton, P. J.; Soumyanath, A. α-Amylase inhibitory activity of some Malaysian plants used to treat diabetes; with particular reference to Phyllanthus amarus J. Ethnopharmacol. 2006, 107, 449-455 10.1016/j.jep.2006.04.004
47. Kumar, S.; Kumar, V.; Prakash, O. Enzymes inhibition and antidiabetic effect of isolated constituents from Dillenia indica BioMed Res. Int. 2013, 2013, 382063 10.1155/2013/382063
48. Rao, V. S.; de Melo, C. L.; Queiroz, M. G.; Lemos, T. L.; Menezes, D. B.; Melo, T. S.; Santos, F. A. Ursolic acid, a pentacyclic triterpene from Sambucus australis, prevents abdominal adiposity in mice fed a high-fat diet J. Med. Food 2011, 14, 1375-1382 10.1089/jmf.2010.0267
49. de Melo, C. L.; Queiroz, M. G.; Arruda Filho, A. C.; Rodrigues, A. M.; de Sousa, D. F.; Almeida, J. G.; Pessoa, O. D.; Silveira, E. R.; Menezes, D. B.; Melo, T. S.; Santos, F. A.; Rao, V. S. Betulinic acid, a natural pentacyclic triterpenoid, prevents abdominal fat accumulation in mice fed a high-fat diet J. Agric. Food Chem. 2009, 57, 8776-8781 10.1021/jf900768w
50. Jabeen, B.; Riaz, N.; Saleem, M.; Naveed, M. A.; Ashraf, M.; Alam, U.; Rafiq, H. M.; Tareen, R. B.; Jabbar, A. Isolation of natural compounds from Phlomis stewartii showing alpha-glucosidase inhibitory activity Phytochemistry 2013, 96, 443-448 10.1016/j.phytochem.2013.09.015
51. Rani, M. P.; Raghu, K. G.; Nair, M. S.; Padmakumari, K. P. Isolation and identification of alpha-glucosidase and protein glycation inhibitors from Stereospermum colais Appl. Biochem. Biotechnol. 2014, 173, 946-956 10.1007/s12010-014-0898-y
52. Wang, Z. W.; Wang, J. S.; Luo, J.; Kong, L. Y. α-Glucosidase inhibitory triterpenoids from the stem barks of Uncaria laevigata Fitoterapia 2013, 90, 30-37 10.1016/j.fitote.2013.07.005
53. He, Q. Q.; Yang, L.; Zhang, J. Y.; Ma, J. N.; Ma, C. M. Chemical constituents of gold-red apple and their alpha-glucosidase inhibitory activities J. Food Sci. 2014, 79, C1970-1983 10.1111/1750-3841.12599
54. Salah El Dine, R.; Ma, Q.; Kandil, Z. A.; El-Halawany, A. M. Triterpenes as uncompetitive inhibitors of alpha-glucosidase from flowers of Punica granatum L Nat. Prod. Res. 2014, 28, 2191-2194 10.1080/14786419.2014.928292
55. Komaki, E.; Yamaguchi, S.; Maru, I.; Kinoshita, M.; Kakehi, K.; Ohta, Y.; Tsukada, Y. Identification of anti-α-amylase components from olive leaf extracts Food Sci. Technol. Res. 2003, 9, 35-39 10.3136/fstr.9.35
56. Hundal, R. S.; Krssak, M.; Dufour, S.; Laurent, D.; Lebon, V.; Chandramouli, V.; Inzucchi, S. E.; Schumann, W. C.; Petersen, K. F.; Landau, B. R.; Shulman, G. I. Mechanism by which metformin reduces glucose production in type 2 diabetes Diabetes 2000, 49, 2063-2069 10.2337/diabetes.49.12.2063
57. Wen, X.; Sun, H.; Liu, J.; Cheng, K.; Zhang, P.; Zhang, L.; Hao, J.; Zhang, L.; Ni, P.; Zographos, S. E.; Leonidas, D. D.; Alexacou, K. M.; Gimisis, T.; Hayes, J. M.; Oikonomakos, N. G. Naturally occurring pentacyclic triterpenes as inhibitors of glycogen phosphorylase: synthesis, structure-activity relationships, and X-ray crystallographic studies J. Med. Chem. 2008, 51, 3540-3554 10.1021/jm8000949
58. Aiston, S.; Coghlan, M. P.; Agius, L. Inactivation of phosphorylase is a major component of the mechanism by which insulin stimulates hepatic glycogen synthesis Eur. J. Biochem. 2003, 270, 2773-2781 10.1046/j.1432-1033.2003.03648.x
59. Jang, S. M.; Kim, M. J.; Choi, M. S.; Kwon, E. Y.; Lee, M. K. Inhibitory effects of ursolic acid on hepatic polyol pathway and glucose production in streptozotocin-induced diabetic mice Metab., Clin. Exp. 2010, 59, 512-519 10.1016/j.metabol.2009.07.040
60. Postic, C.; Shiota, M.; Niswender, K. D.; Jetton, T. L.; Chen, Y.; Moates, J. M.; Shelton, K. D.; Lindner, J.; Cherrington, A. D.; Magnuson, M. A. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase J. Biol. Chem. 1999, 274, 305-315 10.1074/jbc.274.1.305
61. Foster, J. D.; Pederson, B. A.; Nordlie, R. C. Glucose-6-phosphatase structure, regulation, and function: an update Exp. Biol. Med. 1997, 215, 314-332 10.3181/00379727-215-44142
62. Azevedo, M. F.; Camsari, C.; Sa, C. M.; Lima, C. F.; Fernandes-Ferreira, M.; Pereira-Wilson, C. Ursolic acid and luteolin-7-glucoside improve lipid profiles and increase liver glycogen content through glycogen synthase kinase-3 Phytother. Res. 2010, 24 (Suppl. 2) S220-S224 10.1002/ptr.3118
63. Lee, J.; Kim, M. S. The role of GSK3 in glucose homeostasis and the development of insulin resistance Diabetes Res. Clin. Pract. 2007, 77 (Suppl. 1) S49-57 10.1016/j.diabres.2007.01.033
64. Ha do, T.; Tuan, D. T.; Thu, N. B.; Nhiem, N. X.; Ngoc, T. M.; Yim, N.; Bae, K. Palbinone and triterpenes from Moutan Cortex (Paeonia suffruticosa, Paeoniaceae) stimulate glucose uptake and glycogen synthesis via activation of AMPK in insulin-resistant human HepG2 Cells Bioorg. Med. Chem. Lett. 2009, 19, 5556-5559 10.1016/j.bmcl.2009.08.048
65. Viollet, B.; Foretz, M.; Guigas, B.; Horman, S.; Dentin, R.; Bertrand, L.; Hue, L.; Andreelli, F. Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders J. Physiol. 2006, 574, 41-53 10.1113/jphysiol.2006.108506
66. Heiss, E. H.; Kramer, M. P.; Atanasov, A. G.; Beres, H.; Schachner, D.; Dirsch, V. M. Glycolytic switch in response to betulinic acid in non-cancer cells PLoS One 2014, 9, e115683 10.1371/journal.pone.0115683
67. Gerich, J. E. Redefining the clinical management of type 2 diabetes: matching therapy to pathophysiology Eur. J. Clin. Invest. 2002, 32 (Suppl. 3) 46-53 10.1046/j.1365-2362.32.s3.6.x
68. Jang, S. M.; Yee, S. T.; Choi, J.; Choi, M. S.; Do, G. M.; Jeon, S. M.; Yeo, J.; Kim, M. J.; Seo, K. I.; Lee, M. K. Ursolic acid enhances the cellular immune system and pancreatic beta-cell function in streptozotocin-induced diabetic mice fed a high-fat diet Int. Immunopharmacol. 2009, 9, 113-119 10.1016/j.intimp.2008.10.013
69. Jayaprakasam, B.; Olson, L. K.; Schutzki, R. E.; Tai, M. H.; Nair, M. G. Amelioration of obesity and glucose intolerance in high-fat-fed C57BL/6 mice by anthocyanins and ursolic acid in Cornelian cherry (Cornus mas) J. Agric. Food Chem. 2006, 54, 243-248 10.1021/jf0520342
70. Teodoro, T.; Zhang, L.; Alexander, T.; Yue, J.; Vranic, M.; Volchuk, A. Oleanolic acid enhances insulin secretion in pancreatic beta-cells FEBS Lett. 2008, 582, 1375-1380 10.1016/j.febslet.2008.03.026
71. Zhang, Y.; Jayaprakasam, B.; Seeram, N. P.; Olson, L. K.; DeWitt, D.; Nair, M. G. Insulin secretion and cyclooxygenase enzyme inhibition by Cabernet Sauvignon grape skin compounds J. Agric. Food Chem. 2004, 52, 228-233 10.1021/jf034616u
72. Castro, A. J.; Frederico, M. J.; Cazarolli, L. H.; Bretanha, L. C.; Tavares Lde, C.; Buss Zda, S.; Dutra, M. F.; de Souza, A. Z.; Pizzolatti, M. G.; Silva, F. R. Betulinic acid and 1,25(OH)(2) vitamin D(3) share intracellular signal transduction in glucose homeostasis in soleus muscle Int. J. Biochem. Cell Biol. 2014, 48, 18-27 10.1016/j.biocel.2013.11.020
73. Castro, A. J.; Frederico, M. J.; Cazarolli, L. H.; Mendes, C. P.; Bretanha, L. C.; Schmidt, E. C.; Bouzon, Z. L.; de Medeiros Pinto, V. A.; da Fonte Ramos, C.; Pizzolatti, M. G.; Silva, F. R. The mechanism of action of ursolic acid as insulin secretagogue and insulinomimetic is mediated by cross-talk between calcium and kinases to regulate glucose balance Biochim. Biophys. Acta, Gen. Subj. 2015, 1850, 51-61 10.1016/j.bbagen.2014.10.001
74. Zhang, Y. N.; Zhang, W.; Hong, D.; Shi, L.; Shen, Q.; Li, J. Y.; Li, J.; Hu, L. H. Oleanolic acid and its derivatives: new inhibitor of protein tyrosine phosphatase 1B with cellular activities Bioorg. Med. Chem. 2008, 16, 8697-8705 10.1016/j.bmc.2008.07.080
75. Ramirez-Espinosa, J. J.; Rios, M. Y.; Lopez-Martinez, S.; Lopez-Vallejo, F.; Medina-Franco, J. L.; Paoli, P.; Camici, G.; Navarrete-Vazquez, G.; Ortiz-Andrade, R.; Estrada-Soto, S. Antidiabetic activity of some pentacyclic acid triterpenoids, role of PTP-1B: in vitro, in silico, and in vivo approaches Eur. J. Med. Chem. 2011, 46, 2243-2251 10.1016/j.ejmech.2011.03.005
76. Na, M.; Yang, S.; He, L.; Oh, H.; Kim, B. S.; Oh, W. K.; Kim, B. Y.; Ahn, J. S. Inhibition of protein tyrosine phosphatase 1B by ursane-type triterpenes isolated from Symplocos paniculata Planta Med. 2006, 72, 261-263 10.1055/s-2005-873194
77. Zhang, W.; Hong, D.; Zhou, Y.; Zhang, Y.; Shen, Q.; Li, J. Y.; Hu, L. H.; Li, J. Ursolic acid and its derivative inhibit protein tyrosine phosphatase 1B, enhancing insulin receptor phosphorylation and stimulating glucose uptake Biochim. Biophys. Acta, Gen. Subj. 2006, 1760, 1505-1512 10.1016/j.bbagen.2006.05.009
78. Li, D.; Li, W.; Higai, K.; Koike, K. Protein tyrosine phosphatase 1B inhibitory activities of ursane- and lupane-type triterpenes from Sorbus pohuashanensis J. Nat. Med. 2014, 68, 427-431 10.1007/s11418-013-0804-x
79. Choi, J. Y.; Na, M.; Hyun Hwang, I.; Ho Lee, S.; Young Bae, E.; Yeon Kim, B.; Seog Ahn, J. Isolation of betulinic acid, its methyl ester and guaiane sesquiterpenoids with protein tyrosine phosphatase 1B inhibitory activity from the roots of Saussurea lappa C.B. Clarke Molecules 2009, 14, 266-272 10.3390/molecules14010266
80. Jung, S. H.; Ha, Y. J.; Shim, E. K.; Choi, S. Y.; Jin, J. L.; Yun-Choi, H. S.; Lee, J. R. Insulin-mimetic and insulin-sensitizing activities of a pentacyclic triterpenoid insulin receptor activator Biochem. J. 2007, 403, 243-250 10.1042/BJ20061123
81. Li, Y.; Wang, J.; Gu, T.; Yamahara, J.; Li, Y. Oleanolic acid supplement attenuates liquid fructose-induced adipose tissue insulin resistance through the insulin receptor substrate-1/phosphatidylinositol 3-kinase/Akt signaling pathway in rats Toxicol. Appl. Pharmacol. 2014, 277, 155-163 10.1016/j.taap.2014.03.016
82. He, Y.; Li, W.; Li, Y.; Zhang, S.; Wang, Y.; Sun, C. Ursolic acid increases glucose uptake through the PI3K signaling pathway in adipocytes PLoS One 2014, 9, e110711 10.1371/journal.pone.0110711
83. Sato, H.; Genet, C.; Strehle, A.; Thomas, C.; Lobstein, A.; Wagner, A.; Mioskowski, C.; Auwerx, J.; Saladin, R. Anti-hyperglycemic activity of a TGR5 agonist isolated from Olea europaea Biochem. Biophys. Res. Commun. 2007, 362, 793-798 10.1016/j.bbrc.2007.06.130
84. Genet, C.; Strehle, A.; Schmidt, C.; Boudjelal, G.; Lobstein, A.; Schoonjans, K.; Souchet, M.; Auwerx, J.; Saladin, R.; Wagner, A. Structure-activity relationship study of betulinic acid, a novel and selective TGR5 agonist, and its synthetic derivatives: potential impact in diabetes J. Med. Chem. 2010, 53, 178-190 10.1021/jm900872z
85. Bala, V.; Rajagopal, S.; Kumar, D. P.; Nalli, A. D.; Mahavadi, S.; Sanyal, A. J.; Grider, J. R.; Murthy, K. S. Release of GLP-1 and PYY in response to the activation of G protein-coupled bile acid receptor TGR5 is mediated by Epac/PLC-epsilon pathway and modulated by endogenous H2S Front. Physiol. 2014, 5, 420 10.3389/fphys.2014.00420
86. Kumar, D. P.; Rajagopal, S.; Mahavadi, S.; Mirshahi, F.; Grider, J. R.; Murthy, K. S.; Sanyal, A. J. Activation of transmembrane bile acid receptor TGR5 stimulates insulin secretion in pancreatic beta cells Biochem. Biophys. Res. Commun. 2012, 427, 600-605 10.1016/j.bbrc.2012.09.104
87. Nataraju, A.; Saini, D.; Ramachandran, S.; Benshoff, N.; Liu, W.; Chapman, W.; Mohanakumar, T. Oleanolic acid, a plant triterpenoid, significantly improves survival and function of islet allograft Transplantation 2009, 88, 987-994 10.1097/TP.0b013e3181b9cbc4
88. Norris, K.; Norris, F.; Kono, D. H.; Vestergaard, H.; Pedersen, O.; Theofilopoulos, A. N.; Moller, N. P. Expression of protein-tyrosine phosphatases in the major insulin target tissues FEBS Lett. 1997, 415, 243-248 10.1016/S0014-5793(97)01133-2
89. Asante-Appiah, E.; Kennedy, B. P. Protein tyrosine phosphatases: the quest for negative regulators of insulin action Am. J. Physiol.: Endocrinol. Metab. 2003, 284, E663-670 10.1152/ajpendo.00462.2002
90. Galic, S.; Hauser, C.; Kahn, B. B.; Haj, F. G.; Neel, B. G.; Tonks, N. K.; Tiganis, T. Coordinated regulation of insulin signaling by the protein tyrosine phosphatases PTP1B and TCPTP Mol. Cell. Biol. 2005, 25, 819-829 10.1128/MCB.25.2.819-829.2005
91. Nakagawa, Y.; Aoki, N.; Aoyama, K.; Shimizu, H.; Shimano, H.; Yamada, N.; Miyazaki, H. Receptor-type protein tyrosine phosphatase epsilon (PTPepsilonM) is a negative regulator of insulin signaling in primary hepatocytes and liver Zool. Sci. 2005, 22, 169-175 10.2108/zsj.22.169
92. White, M. F. The IRS-signalling system: a network of docking proteins that mediate insulin action Mol. Cell. Biochem. 1998, 182, 3-11 10.1023/A:1006806722619
93. Virkamaki, A.; Ueki, K.; Kahn, C. R. Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance J. Clin. Invest. 1999, 103, 931-943 10.1172/JCI6609
94. Trauner, M.; Claudel, T.; Fickert, P.; Moustafa, T.; Wagner, M. Bile acids as regulators of hepatic lipid and glucose metabolism Dig. Dis. 2010, 28, 220-224 10.1159/000282091
95. MacDonald, P. E.; El-Kholy, W.; Riedel, M. J.; Salapatek, A. M.; Light, P. E.; Wheeler, M. B. The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion Diabetes 2002, 51 (Suppl. 3) S434-S442 10.2337/diabetes.51.2007.S434
96. Buteau, J.; Foisy, S.; Joly, E.; Prentki, M. Glucagon-like peptide 1 induces pancreatic beta-cell proliferation via transactivation of the epidermal growth factor receptor Diabetes 2003, 52, 124-132 10.2337/diabetes.52.1.124
97. Mojsov, S. Glucagon-like peptide-1 (GLP-1) and the control of glucose metabolism in mammals and teleost fish Am. Zool. 2000, 40, 246-258 10.1668/0003-1569(2000)040[0246:GLPGAT]2.0.CO;2
98. Puddu, A.; Sanguineti, R.; Mach, F.; Dallegri, F.; Viviani, G. L.; Montecucco, F. Update on the protective molecular pathways improving pancreatic beta-cell dysfunction Mediators Inflammation 2013, 2013, 750540 10.1155/2013/750540
99. Lee, W.; Yang, E. J.; Ku, S. K.; Song, K. S.; Bae, J. S. Anti-inflammatory effects of oleanolic acid on LPS-induced inflammation in vitro and in vivo Inflammation 2013, 36, 94-102 10.1007/s10753-012-9523-9
100. Qatanani, M.; Lazar, M. A. Mechanisms of obesity-associated insulin resistance: many choices on the menu Genes Dev. 2007, 21, 1443-1455 10.1101/gad.1550907
101. Hybertson, B. M.; Gao, B.; Bose, S. K.; McCord, J. M. Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation Mol. Aspects Med. 2011, 32, 234-246 10.1016/j.mam.2011.10.006
102. Zhang, Z.; Zhou, S.; Jiang, X.; Wang, Y. H.; Li, F.; Wang, Y. G.; Zheng, Y.; Cai, L. The role of the Nrf2/Keap1 pathway in obesity and metabolic syndrome Rev. Endocr. Metab. Disord. 2015, 16, 35-45 10.1007/s11154-014-9305-9
103. Reisman, S. A.; Aleksunes, L. M.; Klaassen, C. D. Oleanolic acid activates Nrf2 and protects from acetaminophen hepatotoxicity via Nrf2-dependent and Nrf2-independent processes Biochem. Pharmacol. 2009, 77, 1273-1282 10.1016/j.bcp.2008.12.028
104. Liu, J.; Wu, Q.; Lu, Y. F.; Pi, J. New insights into generalized hepatoprotective effects of oleanolic acid: key roles of metallothionein and Nrf2 induction Biochem. Pharmacol. 2008, 76, 922-928 10.1016/j.bcp.2008.07.021
105. Lu, Y. F.; Liu, J.; Wu, K. C.; Klaassen, C. D. Protection against phalloidin-induced liver injury by oleanolic acid involves Nrf2 activation and suppression of Oatp1b2 Toxicol. Lett. 2015, 232, 326-332 10.1016/j.toxlet.2014.09.027
106. Gao, D.; Li, Q.; Li, Y.; Liu, Z.; Liu, Z.; Fan, Y.; Han, Z.; Li, J.; Li, K. Antidiabetic potential of oleanolic acid from Ligustrum lucidum Ait Can. J. Physiol. Pharmacol. 2007, 85, 1076-1083 10.1139/Y07-098
107. Jang, D. S.; Lee, G. Y.; Kim, J.; Lee, Y. M.; Kim, J. M.; Kim, Y. S.; Kim, J. S. A new pancreatic lipase inhibitor isolated from the roots of Actinidia arguta Arch. Pharmacal Res. 2008, 31, 666-670 10.1007/s12272-001-1210-9
108. Kim, J.; Lee, Y. S.; Kim, C. S.; Kim, J. S. Betulinic acid has an inhibitory effect on pancreatic lipase and induces adipocyte lipolysis Phytother. Res. 2012, 26, 1103-1106 10.1002/ptr.3672
109. Liu, C.; Li, Y.; Zuo, G.; Xu, W.; Gao, H.; Yang, Y.; Yamahara, J.; Wang, J.; Li, Y. Oleanolic Acid diminishes liquid fructose-induced fatty liver in rats: role of modulation of hepatic sterol regulatory element-binding protein-1c-mediated expression of genes responsible for de novo fatty acid synthesis Evidence-Based Complement. Alternat. Med. 2013, 2013, 534084 10.1155/2013/534084
110. Yunoki, K.; Sasaki, G.; Tokuji, Y.; Kinoshita, M.; Naito, A.; Aida, K.; Ohnishi, M. Effect of dietary wine pomace extract and oleanolic acid on plasma lipids in rats fed high-fat diet and its DNA microarray analysis J. Agric. Food Chem. 2008, 56, 12052-12058 10.1021/jf8026217
111. Jia, Y.; Bhuiyan, M. J.; Jun, H. J.; Lee, J. H.; Hoang, M. H.; Lee, H. J.; Kim, N.; Lee, D.; Hwang, K. Y.; Hwang, B. Y.; Choi, D. W.; Lee, S. J. Ursolic acid is a PPAR-alpha agonist that regulates hepatic lipid metabolism Bioorg. Med. Chem. Lett. 2011, 21, 5876-5880 10.1016/j.bmcl.2011.07.095
112. Sung, H. Y.; Kang, S. W.; Kim, J. L.; Li, J.; Lee, E. S.; Gong, J. H.; Han, S. J.; Kang, Y. H. Oleanolic acid reduces markers of differentiation in 3T3-L1 adipocytes Nutr. Res. (N.Y., NY, U.S.) 2010, 30, 831-839 10.1016/j.nutres.2010.10.001
113. He, Y.; Li, Y.; Zhao, T.; Wang, Y.; Sun, C. Ursolic acid inhibits adipogenesis in 3T3-L1 adipocytes through LKB1/AMPK pathway PLoS One 2013, 8, e70135 10.1371/journal.pone.0070135
114. Dat, N. T.; Cai, X. F.; Rho, M. C.; Lee, H. S.; Bae, K.; Kim, Y. H. The inhibition of diacylglycerol acyltransferase by terpenoids from Youngia koidzumiana Arch. Pharmacal Res. 2005, 28, 164-168 10.1007/BF02977708
115. Lee, W. S.; Im, K. R.; Park, Y. D.; Sung, N. D.; Jeong, T. S. Human ACAT-1 and ACAT-2 inhibitory activities of pentacyclic triterpenes from the leaves of Lycopus lucidus TURCZ Biol. Pharm. Bull. 2006, 29, 382-384 10.1248/bpb.29.382
116. Rudel, L. L.; Lee, R. G.; Cockman, T. L. Acyl coenzyme A: cholesterol acyltransferase types 1 and 2: structure and function in atherosclerosis Curr. Opin. Lipidol. 2001, 12, 121-127 10.1097/00041433-200104000-00005
117. Beysen, C.; Murphy, E. J.; Nagaraja, H.; Decaris, M.; Riiff, T.; Fong, A.; Hellerstein, M. K.; Boyle, P. J. A pilot study of the effects of pioglitazone and rosiglitazone on de novo lipogenesis in type 2 diabetes J. Lipid Res. 2008, 49, 2657-2663 10.1194/jlr.M800165-JLR200
118. Dong, J.; Xu, H.; Xu, H.; Wang, P. F.; Cai, G. J.; Song, H. F.; Wang, C. C.; Dong, Z. T.; Ju, Y. J.; Jiang, Z. Y. Nesfatin-1 stimulates fatty-acid oxidation by activating AMP-activated protein kinase in STZ-induced type 2 diabetic mice PLoS One 2013, 8, e83397 10.1371/journal.pone.0083397
119. Murase, T.; Misawa, K.; Minegishi, Y.; Aoki, M.; Ominami, H.; Suzuki, Y.; Shibuya, Y.; Hase, T. Coffee polyphenols suppress diet-induced body fat accumulation by downregulating SREBP-1c and related molecules in C57BL/6J mice Am. J. Physiol.: Endocrinol. Metab. 2011, 300, E122-E133 10.1152/ajpendo.00441.2010
120. Zou, M. H.; Hou, X. Y.; Shi, C. M.; Kirkpatick, S.; Liu, F.; Goldman, M. H.; Cohen, R. A. Activation of 5′-AMP-activated kinase is mediated through c-Src and phosphoinositide 3-kinase activity during hypoxia-reoxygenation of bovine aortic endothelial cells. Role of peroxynitrite J. Biol. Chem. 2003, 278, 34003-34010 10.1074/jbc.M300215200
121. Vazquez, M.; Roglans, N.; Cabrero, A.; Rodriguez, C.; Adzet, T.; Alegret, M.; Sanchez, R. M.; Laguna, J. C. Bezafibrate induces acyl-CoA oxidase mRNA levels and fatty acid peroxisomal beta-oxidation in rat white adipose tissue Mol. Cell. Biochem. 2001, 216, 71-78 10.1023/A:1011060615234
122. Tanaka, T.; Masuzaki, H.; Ebihara, K.; Ogawa, Y.; Yasue, S.; Yukioka, H.; Chusho, H.; Miyanaga, F.; Miyazawa, T.; Fujimoto, M.; Kusakabe, T.; Kobayashi, N.; Hayashi, T.; Hosoda, K.; Nakao, K. Transgenic expression of mutant peroxisome proliferator-activated receptor gamma in liver precipitates fasting-induced steatosis but protects against high-fat diet-induced steatosis in mice Metab., Clin. Exp. 2005, 54, 1490-1498 10.1016/j.metabol.2005.05.015
123. Chu, X.; He, X.; Shi, Z.; Li, C.; Guo, F.; Li, S.; Li, Y.; Na, L.; Sun, C. Ursolic acid increases energy expenditure through enhancing free fatty acid uptake and beta-oxidation via an UCP3/AMPK-dependent pathway in skeletal muscle Mol. Nutr. Food Res. 2015, 59, 1491-1503 10.1002/mnfr.201400670
124. Rousset, S.; Alves-Guerra, M. C.; Mozo, J.; Miroux, B.; Cassard-Doulcier, A. M.; Bouillaud, F.; Ricquier, D. The biology of mitochondrial uncoupling proteins Diabetes 2004, 53 (Suppl. 1) S130-S135 10.2337/diabetes.53.2007.S130
125. Quan, H. Y.; Kim do, Y.; Kim, S. J.; Jo, H. K.; Kim, G. W.; Chung, S. H. Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK-mTOR-SREBP signaling pathway Biochem. Pharmacol. 2013, 85, 1330-1340 10.1016/j.bcp.2013.02.007
126. Kong, T.; Li, S.; Li, Y.; Sun, C. [Oleanolic acid-stimulated lipolysis in primary adipocytes and its mechanisms] Weisheng Yanjiu 2011, 40, 27-29
127. Li, Y.; Kang, Z.; Li, S.; Kong, T.; Liu, X.; Sun, C. Ursolic acid stimulates lipolysis in primary-cultured rat adipocytes Mol. Nutr. Food Res. 2010, 54, 1609-1617 10.1002/mnfr.200900564
128. Kim, J.; Jang, D. S.; Kim, H.; Kim, J. S. Anti-lipase and lipolytic activities of ursolic acid isolated from the roots of Actinidia arguta Arch. Pharmacal Res. 2009, 32, 983-987 10.1007/s12272-009-1702-3
129. Chung, M. Y.; Rho, M. C.; Lee, S. W.; Park, H. R.; Kim, K.; Lee, I. A.; Kim, D. H.; Jeune, K. H.; Lee, H. S.; Kim, Y. K. Inhibition of diacylglycerol acyltransferase by betulinic acid from Alnus hirsuta Planta Med. 2006, 72, 267-269 10.1055/s-2005-916178
130. Claus, T. H.; Lowe, D. B.; Liang, Y.; Salhanick, A. I.; Lubeski, C. K.; Yang, L.; Lemoine, L.; Zhu, J.; Clairmont, K. B. Specific inhibition of hormone-sensitive lipase improves lipid profile while reducing plasma glucose J. Pharmacol. Exp. Ther. 2005, 315, 1396-1402 10.1124/jpet.105.086926
131. Jung, U. J.; Choi, M. S. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease Int. J. Mol. Sci. 2014, 15, 6184-6223 10.3390/ijms15046184
132. Kim, H. S.; Sung, H. Y.; Kim, M. S.; Kim, J. L.; Kang, M. K.; Gong, J. H.; Park, H. S.; Kang, Y. H. Oleanolic acid suppresses resistin induction in adipocytes by modulating Tyk-STAT signaling Nutr. Res. (N.Y., NY, U.S.) 2013, 33, 144-153 10.1016/j.nutres.2012.12.006
133. Angulo, P.; Lindor, K. D. Non-alcoholic fatty liver disease J. Gastroenterol. Hepatol. 2002, 17 (Suppl.) S186-S190 10.1046/j.1440-1746.17.s1.10.x
134. Choudhury, J.; Sanyal, A. J. Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease Clin. Liver Dis. 2004, 8, 575-594 10.1016/j.cld.2004.04.006
135. James, O. F.; Day, C. P. Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance J. Hepatol. 1998, 29, 495-501 10.1016/S0168-8278(98)80073-1
136. Zhou, X.; Zeng, X. Y.; Wang, H.; Li, S.; Jo, E.; Xue, C. C.; Tan, M.; Molero, J. C.; Ye, J. C. Hepatic FoxO1 acetylation is involved in oleanolic acid-induced memory of glycemic control: novel findings from Study 2 PLoS One 2014, 9, e107231 10.1371/journal.pone.0107231
137. Lee, W. J.; Kim, M.; Park, H. S.; Kim, H. S.; Jeon, M. J.; Oh, K. S.; Koh, E. H.; Won, J. C.; Kim, M. S.; Oh, G. T.; Yoon, M.; Lee, K. U.; Park, J. Y. AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARalpha and PGC-1 Biochem. Biophys. Res. Commun. 2006, 340, 291-295 10.1016/j.bbrc.2005.12.011
138. Li, Y.; Xu, S.; Mihaylova, M. M.; Zheng, B.; Hou, X.; Jiang, B.; Park, O.; Luo, Z.; Lefai, E.; Shyy, J. Y.; Gao, B.; Wierzbicki, M.; Verbeuren, T. J.; Shaw, R. J.; Cohen, R. A.; Zang, M. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice Cell Metab. 2011, 13, 376-388 10.1016/j.cmet.2011.03.009
139. Wang, X.; Ye, X. L.; Liu, R.; Chen, H. L.; Bai, H.; Liang, X.; Zhang, X. D.; Wang, Z.; Li, W. L.; Hai, C. X. Antioxidant activities of oleanolic acid in vitro: possible role of Nrf2 and MAP kinases Chem.-Biol. Interact. 2010, 184, 328-337 10.1016/j.cbi.2010.01.034
140. Andrikopoulos, N. K.; Kaliora, A. C.; Assimopoulou, A. N.; Papageorgiou, V. P. Inhibitory activity of minor polyphenolic and nonpolyphenolic constituents of olive oil against in vitro low-density lipoprotein oxidation J. Med. Food 2002, 5, 1-7 10.1089/109662002753723160
141. Checker, R.; Sandur, S. K.; Sharma, D.; Patwardhan, R. S.; Jayakumar, S.; Kohli, V.; Sethi, G.; Aggarwal, B. B.; Sainis, K. B. Potent anti-inflammatory activity of ursolic acid, a triterpenoid antioxidant, is mediated through suppression of NF-kappaB, AP-1 and NF-AT PLoS One 2012, 7, e31318 10.1371/journal.pone.0031318
142. Somova, L. O.; Nadar, A.; Rammanan, P.; Shode, F. O. Cardiovascular, antihyperlipidemic and antioxidant effects of oleanolic and ursolic acids in experimental hypertension Phytomedicine 2003, 10, 115-121 10.1078/094471103321659807
143. Sena, C. M.; Pereira, A. M.; Seica, R. Endothelial dysfunction-a major mediator of diabetic vascular disease Biochim. Biophys. Acta, Mol. Basis Dis. 2013, 1832, 2216-2231 10.1016/j.bbadis.2013.08.006
144. Rodriguez-Rodriguez, R.; Stankevicius, E.; Herrera, M. D.; Ostergaard, L.; Andersen, M. R.; Ruiz-Gutierrez, V.; Simonsen, U. Oleanolic acid induces relaxation and calcium-independent release of endothelium-derived nitric oxide Br. J. Pharmacol. 2008, 155, 535-546 10.1038/bjp.2008.289
145. Fu, J. Y.; Qian, L. B.; Zhu, L. G.; Liang, H. T.; Tan, Y. N.; Lu, H. T.; Lu, J. F.; Wang, H. P.; Xia, Q. Betulinic acid ameliorates endothelium-dependent relaxation in L-NAME-induced hypertensive rats by reducing oxidative stress Eur. J. Pharm. Sci. 2011, 44, 385-391 10.1016/j.ejps.2011.08.025
146. Qian, L. B.; Fu, J. Y.; Cai, X.; Xia, M. L. Betulinic acid inhibits superoxide anion-mediated impairment of endothelium-dependent relaxation in rat aortas Indian J. Pharmacol. 2012, 44, 588-592 10.4103/0253-7613.100382
147. Jin, S. W.; Choi, C. Y.; Hwang, Y. P.; Kim, H. G.; Kim, S. J.; Chung, Y. C.; Lee, K. J.; Jeong, T. C.; Jeong, H. G. Betulinic acid increases eNOS phosphorylation and NO synthesis via the calcium-signaling pathway J. Agric. Food Chem. 2016, 64, 785-791 10.1021/acs.jafc.5b05416
148. Steinkamp-Fenske, K.; Bollinger, L.; Voller, N.; Xu, H.; Yao, Y.; Bauer, R.; Forstermann, U.; Li, H. Ursolic acid from the Chinese herb danshen (Salvia miltiorrhiza L.) upregulates eNOS and downregulates Nox4 expression in human endothelial cells Atherosclerosis 2007, 195, e104-111 10.1016/j.atherosclerosis.2007.03.028
149. Steinkamp-Fenske, K.; Bollinger, L.; Xu, H.; Yao, Y.; Horke, S.; Forstermann, U.; Li, H. Reciprocal regulation of endothelial nitric-oxide synthase and NADPH oxidase by betulinic acid in human endothelial cells J. Pharmacol. Exp. Ther. 2007, 322, 836-842 10.1124/jpet.107.123356
150. Pendyala, S.; Natarajan, V. Redox regulation of Nox proteins Respir. Physiol. Neurobiol. 2010, 174, 265-271 10.1016/j.resp.2010.09.016
151. Yang, J. J.; Gong, Y.; Shi, J.; Qi, M. Y. [Study on the effect of ursolic acid (UA) on the myocardial fibrosis of experimental diabetic mice] Zhongguo Yingyong Shenglixue Zazhi 2013, 29, 353-356
152. Du, Y.; Ko, K. M. Oleanolic acid protects against myocardial ischemia-reperfusion injury by enhancing mitochondrial antioxidant mechanism mediated by glutathione and alpha-tocopherol in rats Planta Med. 2006, 72, 222-227 10.1055/s-2005-916197
153. Senthil, S.; Chandramohan, G.; Pugalendi, K. V. Isomers (oleanolic and ursolic acids) differ in their protective effect against isoproterenol-induced myocardial ischemia in rats Int. J. Cardiol. 2007, 119, 131-133 10.1016/j.ijcard.2006.07.108
154. Yang, Y.; Li, C.; Xiang, X.; Dai, Z.; Chang, J.; Zhang, M.; Cai, H.; Zhang, H.; Zhang, M.; Guo, Y.; Wu, Z. Ursolic acid prevents endoplasmic reticulum stress-mediated apoptosis induced by heat stress in mouse cardiac myocytes J. Mol. Cell. Cardiol. 2014, 67, 103-111 10.1016/j.yjmcc.2013.12.018
155. Gugliucci, A.; Bendayan, M. Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells Diabetologia 1996, 39, 149-160 10.1007/BF00403957
156. Dunlop, M. Aldose reductase and the role of the polyol pathway in diabetic nephropathy Kidney Int. 2000, 77, S3-S12 10.1046/j.1523-1755.2000.07702.x
157. Zeng, X. Y.; Wang, Y. P.; Cantley, J.; Iseli, T. J.; Molero, J. C.; Hegarty, B. D.; Kraegen, E. W.; Ye, Y.; Ye, J. M. Oleanolic acid reduces hyperglycemia beyond treatment period with Akt/FoxO1-induced suppression of hepatic gluconeogenesis in type-2 diabetic mice PLoS One 2012, 7, e42115 10.1371/journal.pone.0042115
158. Zhou, Y.; Li, J. S.; Zhang, X.; Wu, Y. J.; Huang, K.; Zheng, L. Ursolic acid inhibits early lesions of diabetic nephropathy Int. J. Mol. Med. 2010, 26, 565-570 10.3892/ijmm-00000500
159. Wang, Z. H.; Hsu, C. C.; Huang, C. N.; Yin, M. C. Anti-glycative effects of oleanolic acid and ursolic acid in kidney of diabetic mice Eur. J. Pharmacol. 2010, 628, 255-260 10.1016/j.ejphar.2009.11.019
160. Yin, M. C.; Chan, K. C. Nonenzymatic antioxidative and antiglycative effects of oleanolic acid and ursolic acid J. Agric. Food Chem. 2007, 55, 7177-7181 10.1021/jf071242m
161. Yin, M. C. Inhibitory effects and actions of pentacyclic triterpenes upon glycation BioMedicine 2015, 5, 13 10.7603/s40681-015-0013-x
162. Lu, J.; Wu, D. M.; Zheng, Y. L.; Hu, B.; Zhang, Z. F.; Ye, Q.; Liu, C. M.; Shan, Q.; Wang, Y. J. Ursolic acid attenuates d -galactose-induced inflammatory response in mouse prefrontal cortex through inhibiting AGEs/RAGE/NF-κB pathway activation Cerebral Cortex 2010, 20, 2540-2548 10.1093/cercor/bhq002
163. Jeong, D. W.; Kim, Y. H.; Kim, H. H.; Ji, H. Y.; Yoo, S. D.; Choi, W. R.; Lee, S. M.; Han, C. K.; Lee, H. S. Dose-linear pharmacokinetics of oleanolic acid after intravenous and oral administration in rats Biopharm. Drug Dispos. 2007, 28, 51-57 10.1002/bdd.530
164. Chen, Q.; Luo, S.; Zhang, Y.; Chen, Z. Development of a liquid chromatography-mass spectrometry method for the determination of ursolic acid in rat plasma and tissue: application to the pharmacokinetic and tissue distribution study Anal. Bioanal. Chem. 2011, 399, 2877-2884 10.1007/s00216-011-4651-x
165. Godugu, C.; Patel, A. R.; Doddapaneni, R.; Somagoni, J.; Singh, M. Approaches to improve the oral bioavailability and effects of novel anticancer drugs berberine and betulinic acid PLoS One 2014, 9, e89919 10.1371/journal.pone.0089919
166. Chen, Y.; Liu, J.; Yang, X.; Zhao, X.; Xu, H. Oleanolic acid nanosuspensions: preparation, in-vitro characterization and enhanced hepatoprotective effect J. Pharm. Pharmacol. 2005, 57, 259-264 10.1211/0022357055407
167. Qian, Z.; Wang, X.; Song, Z.; Zhang, H.; Zhou, S.; Zhao, J.; Wang, H. A phase I trial to evaluate the multiple-dose safety and antitumor activity of ursolic acid liposomes in subjects with advanced solid tumors BioMed Res. Int. 2015, 2015, 809714 10.1155/2015/809714
168. Wang, Y. Y.; Yang, Y. X.; Zhe, H.; He, Z. X.; Zhou, S. F. Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties Drug Des., Dev. Ther. 2014, 8, 2075-2088 10.2147/DDDT.S68872
169. Wu, P.; Zheng, J.; Huang, T.; Li, D.; Hu, Q.; Cheng, A.; Jiang, Z.; Jiao, L.; Zhao, S.; Zhang, K. Synthesis and evaluation of novel triterpene analogues of ursolic acid as potential antidiabetic agent PLoS One 2015, 10, e0138767 10.1371/journal.pone.0138767
170. Pergola, P. E.; Krauth, M.; Huff, J. W.; Ferguson, D. A.; Ruiz, S.; Meyer, C. J.; Warnock, D. G. Effect of bardoxolone methyl on kidney function in patients with T2D and stage 3b-4 CKD Am. J. Nephrol. 2011, 33, 469-476 10.1159/000327599
171. Pergola, P. E.; Raskin, P.; Toto, R. D.; Meyer, C. J.; Huff, J. W.; Grossman, E. B.; Krauth, M.; Ruiz, S.; Audhya, P.; Christ-Schmidt, H.; Wittes, J.; Warnock, D. G.; Investigators, B. S. Bardoxolone methyl and kidney function in CKD with type 2 diabetes N. Engl. J. Med. 2011, 365, 327-336 10.1056/NEJMoa1105351
172. de Zeeuw, D.; Akizawa, T.; Audhya, P.; Bakris, G. L.; Chin, M.; Christ-Schmidt, H.; Goldsberry, A.; Houser, M.; Krauth, M.; Lambers Heerspink, H. J.; McMurray, J. J.; Meyer, C. J.; Parving, H. H.; Remuzzi, G.; Toto, R. D.; Vaziri, N. D.; Wanner, B.; Wittes, J.; Wrolstad, D.; Chertow, G. M.; Investigators, B. T. Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease N. Engl. J. Med. 2013, 369, 2492-2503 10.1056/NEJMoa1306033
173. Wang, X.; Chen, Y.; Abdelkader, D.; Hassan, W.; Sun, H.; Liu, J. Combination therapy with oleanolic acid and metformin as a synergistic treatment for diabetes J. Diabetes Res. 2015, 2015, 973287 10.1155/2015/973287
174. Liu, J.; Lu, Y. F.; Zhang, Y.; Wu, K. C.; Fan, F.; Klaassen, C. D. Oleanolic acid alters bile acid metabolism and produces cholestatic liver injury in mice Toxicol. Appl. Pharmacol. 2013, 272, 816-824 10.1016/j.taap.2013.08.003
175. Lu, Y. F.; Wan, X. L.; Xu, Y.; Liu, J. Repeated oral administration of oleanolic acid produces cholestatic liver injury in mice Molecules 2013, 18, 3060-3071 10.3390/molecules18033060